This client is a private company based in Kentucky with a diverse portfolio of businesses. They cover approximately 2,600 lives and extend the RxManage Program at a $0 co-pay to both employees and dependents.
RxManage transformed affordability and access by delivering brand-name medications from licensed pharmacies in Tier 1 countries (New Zealand, Australia, Canada, and the UK) at up to 70% less cost, while maintaining a $0 co-pay for employees. The program launched in January 2023.
The program delivered meaningful cost reductions while expanding employee access to medications. Between February and July 2025, RxManage processed 173 claims, achieving $482,020 in savings—a 59% reduction in medication costs. Though these claims accounted for just 1% of total claims, they generated a 15% reduction in overall medication costs for the group.
|
Claims from |
No. of claims |
% Claim total |
Cost |
PBM price |
Savings |
%Savings |
|
PBM |
17,406 |
99.02% |
$2,430,652.45 |
$2,430,652.45 |
$0.00 |
0.00% |
|
RxManage |
173 |
0.98% |
$332,362.50 |
$814,382.87 |
$482,020.37 |
59.19% |
|
Grand Total |
17,579 |
100.00% |
$2,763,014.95 |
$3,245,035.32 |
$482,020.37 |
14.85% |
Improving the overall efficiency of the benefits program allowed both the employer and employees to realize cost savings while supporting better adherence to prescribed medications, potentially reducing avoidable emergency room visits.